Cardiovascular diseases.http://www.who.int/mediacentre/factsheets/fs317/en/index.html,
Drazner MH: The progression of hypertensive heart disease. Circulation. 2011, 123 (3): 327-334. 10.1161/CIRCULATIONAHA.108.845792.
Article
PubMed
Google Scholar
Dickhout JG, Carlisle RE, Austin RC: Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis. Circ Res. 2011, 108 (5): 629-642. 10.1161/CIRCRESAHA.110.226803.
Article
CAS
PubMed
Google Scholar
Gheorghiade M, Ambrosy A: Heart failure in 2010: one step forward, two steps back. Nat Rev Cardiol. 2011, 8 (2): 72-73. 10.1038/nrcardio.2010.205.
Article
PubMed
Google Scholar
Johnston C: Functional foods as modifiers of cardiovascular disease. Am J Lifestyle Med. 2009, 3 (1 Suppl): 39S-43S. 10.1177/1559827609332320.
Article
PubMed
PubMed Central
Google Scholar
Ensminger AH: Foods & nutrition encyclopedia, vol. 1. 1994, CRC Press
Google Scholar
Lawson LD, Ransom DK, Hughes BG: Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products. Thromb Res. 1992, 65 (2): 141-156. 10.1016/0049-3848(92)90234-2.
Article
CAS
PubMed
Google Scholar
Chang SH, Liu CJ, Kuo CH, Chen H, Lin WY, Teng KY, Chang SW, Tsai CH, Tsai FJ, Huang CY: Garlic oil alleviates MAPKs- and IL-6-mediated diabetes-related cardiac hypertrophy in STZ-induced DM rats. Evid Based Complement Alternat Med. 2011, 2011: 950150-
PubMed
Google Scholar
Brandle M, al Makdessi S, Weber RK, Dietz K, Jacob R: Prolongation of life span in hypertensive rats by dietary interventions. Effects of garlic and linseed oil. Basic Res Cardiol. 1997, 92 (4): 223-232. 10.1007/BF00788517.
Article
CAS
PubMed
Google Scholar
Thandapilly SJ, Louis XL, Yang T, Stringer DM, Yu L, Zhang S, Wigle J, Kardami E, Zahradka P, Taylor C: Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway. Eur J Pharmacol. 2011, 668 (1–2): 217-224.
Article
CAS
PubMed
Google Scholar
Rahman K, Lowe GM: Garlic and cardiovascular disease: a critical review. J Nutr. 2006, 136 (3 Suppl): 736S-740S.
CAS
PubMed
Google Scholar
Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T: Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2008, 8: 13-10.1186/1471-2261-8-13.
Article
PubMed
PubMed Central
Google Scholar
Schluter KD, Simm A, Schafer M, Taimor G, Piper HM: Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am J Physiol. 1999, 276 (5 Pt 2): H1655-H1663.
CAS
PubMed
Google Scholar
Keys JR, Koch WJ: The adrenergic pathway and heart failure. Recent Prog Horm Res. 2004, 59: 13-30. 10.1210/rp.59.1.13.
Article
CAS
PubMed
Google Scholar
Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990, 82 (5): 1730-1736. 10.1161/01.CIR.82.5.1730.
Article
CAS
PubMed
Google Scholar
Givvimani S, Munjal C, Gargoum R, Sen U, Tyagi N, Vacek JC, Tyagi SC: Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol. 2011, 110 (4): 1093-1100. 10.1152/japplphysiol.01064.2010.
Article
CAS
PubMed
PubMed Central
Google Scholar
Morihara N, Sumioka I, Ide N, Moriguchi T, Uda N, Kyo E: Aged garlic extract maintains cardiovascular homeostasis in mice and rats. J Nutr. 2006, 136 (3 Suppl): 777S-781S.
CAS
PubMed
Google Scholar
Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F: Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation. 2009, 120 (10): 888-896. 10.1161/CIRCULATIONAHA.108.833491.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yong QC, Hu LF, Wang S, Huang D, Bian JS: Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl. Cardiovasc Res. 2010, 88 (3): 482-491. 10.1093/cvr/cvq248.
Article
CAS
PubMed
Google Scholar
Li L, Hsu A, Moore PK: Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation–a tale of three gases!. Pharmacol Ther. 2009, 123 (3): 386-400. 10.1016/j.pharmthera.2009.05.005.
Article
CAS
PubMed
Google Scholar
McMullen JR, Jennings GL: Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol. 2007, 34 (4): 255-262. 10.1111/j.1440-1681.2007.04585.x.
Article
CAS
PubMed
Google Scholar
Dorn GW: Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res. 2009, 81 (3): 465-473.
Article
CAS
PubMed
Google Scholar
Narula J, Haider N, Arbustini E, Chandrashekhar Y: Mechanisms of disease: apoptosis in heart failure–seeing hope in death. Nat Clin Pract Cardiovasc Med. 2006, 3 (12): 681-688. 10.1038/ncpcardio0710.
Article
CAS
PubMed
Google Scholar
Goldspink DF, Burniston JG, Tan LB: Cardiomyocyte death and the ageing and failing heart. Exp Physiol. 2003, 88 (3): 447-458. 10.1113/eph8802549.
Article
CAS
PubMed
Google Scholar
Takimoto E, Kass DA: Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension. 2007, 49 (2): 241-248.
Article
CAS
PubMed
Google Scholar
Wojciechowski P, Juric D, Louis XL, Thandapilly SJ, Yu L, Taylor C, Netticadan T: Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats. J Nutr. 2010, 140 (5): 962-968. 10.3945/jn.109.115006.
Article
CAS
PubMed
Google Scholar
Thandapilly SJ, Wojciechowski P, Behbahani J, Louis XL, Yu L, Juric D, Kopilas MA, Anderson HD, Netticadan T: Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens. 2010, 23 (2): 192-196. 10.1038/ajh.2009.228.
Article
CAS
PubMed
Google Scholar
Schraml E, Quan P, Stelzer I, Fuchs R, Skalicky M, Viidik A, Schauenstein K: Norepinephrine treatment and aging lead to systemic and intracellular oxidative stress in rats. Exp Gerontol. 2007, 42 (11): 1072-1078. 10.1016/j.exger.2007.08.003.
Article
CAS
PubMed
Google Scholar
Jefremov V, Zilmer M, Zilmer K, Bogdanovic N, Karelson E: Antioxidative effects of plant polyphenols: from protection of G protein signaling to prevention of age-related pathologies. Ann N Y Acad Sci. 2007, 1095: 449-457. 10.1196/annals.1397.048.
Article
CAS
PubMed
Google Scholar
Butt MS, Sultan MT, Iqbal J: Garlic: nature's protection against physiological threats. Crit Rev Food Sci Nutr. 2009, 49 (6): 538-551. 10.1080/10408390802145344.
Article
CAS
PubMed
Google Scholar
Nakao A, Sugimoto R, Billiar TR, McCurry KR: Therapeutic antioxidant medical gas. J Clin Biochem Nutr. 2009, 44 (1): 1-13. 10.3164/jcbn.08-193R.
Article
CAS
PubMed
Google Scholar
Liu C, Cao F, Tang QZ, Yan L, Dong YG, Zhu LH, Wang L, Bian ZY, Li H: Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways. J Nutr Biochem. 2010, 21 (12): 1238-1250. 10.1016/j.jnutbio.2009.11.001.
Article
CAS
PubMed
Google Scholar
Asdaq SM, Inamdar MN: Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril. Phytomedicine. 2010, 17 (13): 1016-1026. 10.1016/j.phymed.2010.07.012.
Article
CAS
PubMed
Google Scholar
Sangeetha T, Darlin Quine S: Preventive effect of S-allyl cysteine sulphoxide (Alliin) on mitochondrial dysfunction in normal and isoproterenol induced cardiotoxicity in male Wistar rats: a histopathological study. Mol Cell Biochem. 2009, 328 (1–2): 1-8.
Article
CAS
PubMed
Google Scholar
Sun X, Ku DD: Allicin in garlic protects against coronary endothelial dysfunction and right heart hypertrophy in pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol. 2006, 291 (5): H2431-H2438. 10.1152/ajpheart.00384.2006.
Article
CAS
PubMed
Google Scholar